Immunic (IMUX) Cash from Operations Growth (1y) (2014 - 2026)
Immunic (IMUX) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Immunic |
384.84 Mn |
198.21 Mn |
- |
20.55% |
| Date | Value |
|---|
| Mar 31, 2026 |
20.55% |
| Dec 31, 2025 |
16.03% |
| Sep 30, 2025 |
3.15% |
| Jun 30, 2025 |
-44.43% |
| Mar 31, 2025 |
9.15% |
| Dec 31, 2024 |
-63.71% |
| Sep 30, 2024 |
-20.12% |
| Jun 30, 2024 |
14.70% |
| Mar 31, 2024 |
-22.84% |
| Dec 31, 2023 |
7.13% |
| Sep 30, 2023 |
-27.33% |
| Jun 30, 2023 |
-26.73% |
| Mar 31, 2023 |
5.65% |
| Dec 31, 2022 |
36.22% |
| Sep 30, 2022 |
22.75% |
| Jun 30, 2022 |
45.65% |
| Mar 31, 2022 |
-59.72% |
| Dec 31, 2021 |
-69.60% |
| Sep 30, 2021 |
-47.83% |
| Jun 30, 2021 |
-214.35% |
